XTL Biopharmaceuticals Ltd. (XTLB)

XTL Biopharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-1.78	-1.35	0.44	-2.95	-0.76
Other Operating Activities	1.08	0.45	-1.48	2.1	-0.15
Operating Cash Flow	-0.71	-0.9	-1.05	-0.85	-0.91
Capital Expenditures	0	0	0	-0	-0
Change in Investments	0.04	0.04	0.01	0.03	2.11
Investing Cash Flow	0.04	0.04	0.01	0.03	2.11
Other Financing Activities	-	-	0.39	-	-
Financing Cash Flow	0	0	0.39	0	0
Exchange Rate Effect	-0.03	-0.01	-0.01	-0.01	-0
Net Cash Flow	-0.67	-0.87	-0.66	-0.82	1.2
Free Cash Flow	-0.71	-0.9	-1.05	-0.85	-0.91
Free Cash Flow Per Share	-0.13	-0.17	-0.20	-0.17	-0.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).